June 14, 2012
![]() |
Tyler Jacks, Ph.D.Director, Koch Institute for Integrative Cancer Research Jacqueline Lees, Ph.D. Introductory Remarks and Overview |
![]() |
Stephen Baylin, M.D.Deputy Director, Professor of Oncology and Medicine “The Cancer Epigenome and Therapeutic Implications” |
![]() |
Kristian Helin, Ph.D.Director of the Biotech Research & Innovation Centre (BRIC) “Functional roles of TET proteins in DNA methylation, stem cells and cancer” |
![]() |
Peter W. Laird, Ph.D.Director of the USC Epigenome Center “Exploring the Cancer Methylome” |
![]() |
Richard Young, Ph.D.Member, Whitehead Institute “Collaboration between transcriptional and epigenetic regulators” |
![]() |
Jay Bradner, M.D.Staff Physician, Hematologic Malignancies “Bromodomain Inhibition as Cancer Therapy” |
![]() |
Victoria Richon, Ph.D.Vice President of Biological Sciences “Protein Methyltransferase Inhibitors as Personalized Cancer Therapeutics” |
![]() |
Jacqueline Lees, Ph.D.Professor of Biology “Role of Bmi1 in intestinal development and tumorigenesis” |
![]() |
Laurie Boyer, Ph.D.Sizer Career Development Assistant Professor of Biology “Dynamic and Coordinated Regulation of Developmental Transitions in the Cardiac Lineage” |
![]() |
Scott Armstrong, M.D., Ph.D.Associate Professor of Pediatrics “Epigenetic Mechanisms and Leukemia Development” |
![]() |
John Dick, Ph.D.Senior Scientist, Campbell Family Cancer Research Institute “Stem Cells in Cancer: Do they matter?” |
![]() |
Tyler Jacks, Ph.D.Director, David H. Koch Institute for Integrative Cancer Research Closing Remarks |